source
- FDA approves AstraZeneca’s baxdrostat for select hypertension patientsAstraZeneca announced that the U.S. Food and Drug Administration has granted approval for its blood‑pressure pill baxdrostat, targeting a specific group of patients with hypertension. The approval…
- Amgen defends Tavneos as FDA, European regulators and Japanese doctors raise safety concernsAmgen said it continues to support its rare-disease therapy Tavneos despite recent safety alerts. The U.S. FDA has indicated it wants the drug removed from the market after a report of 20 deaths l…